| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Endonovo Therapeutics, Inc. (ENDV) has 0 insiders with recent SEC Form 4 filings, including 135 buys and 0 sells. ENDV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 20, 2018 | Mann Michael Scott | President | Buy | 9,000 | $0.02 | $195.00 | - | |
| Dec 13, 2018 | Mann Michael Scott | President | Buy | 17,000 | $0.02 | $375.40 | - | |
| Dec 10, 2018 | Mann Michael Scott | President | Buy | 28,200 | $0.02 | $671.56 | - | |
| Dec 6, 2018 | Mann Michael Scott | President | Buy | 26,600 | $0.03 | $782.24 | - | |
| Dec 3, 2018 | Mann Michael Scott | President | Buy | 34,100 | $0.03 | $963.80 | - | |
| Nov 28, 2018 | Mann Michael Scott | President | Buy | 35,500 | $0.03 | $1,021.55 | - | |
| Nov 23, 2018 | Mann Michael Scott | President | Buy | 20,000 | $0.03 | $589.40 | - | |
| Nov 21, 2018 | Mann Michael Scott | President | Buy | 36,000 | $0.03 | $1,009.70 | - |